InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Schwartz Elissa J., Director. Insider active across 1 companies, notably Galectin Therapeutics INC. Aggregated, 2 reports have been logged. Total volume traded: €4k. The latest transaction was filed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€1,7681,000 shares@ €1.76780.0012% mcap50.0% of flow
Common Stock
SEC:0001133416-22-000012:0·
Ideal exit: 18 Oct 2022 (T+270)
€1,7681,000 shares@ €1.7678100.0% of flow
Common Stock
SEC:0001133416-22-000012·
Ideal exit: 18 Oct 2022 (T+270)
2 of 2 declarations
About Schwartz Elissa J.
Elissa J. Schwartz is a Director at GALECTIN THERAPEUTICS INC. She is involved in strategic decision-making and overseeing the company's activities. Her experience and knowledge of the industry are valuable assets in guiding GALECTIN THERAPEUTICS towards its goals.
